User profiles for Jochen Reiser
Jochen Reiser MD PhDUniversity Of Texas Medical Branch Verified email at utmb.edu Cited by 26821 |
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
Focal segmental glomerulosclerosis (FSGS) is a cause of proteinuric kidney disease,
compromising both native and transplanted kidneys. Treatment is limited because of a complex …
compromising both native and transplanted kidneys. Treatment is limited because of a complex …
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis
Focal segmental glomerulosclerosis (FSGS) is a glomerular disease characterized by
proteinuria, progression to end-stage renal disease, and recurrence of proteinuria after kidney …
proteinuria, progression to end-stage renal disease, and recurrence of proteinuria after kidney …
Induction of TRPC6 channel in acquired forms of proteinuric kidney disease
…, M Kretzler, SJ Shankland, J Reiser - Journal of the …, 2007 - journals.lww.com
Injury to podocytes and their slit diaphragms typically leads to marked proteinuria. Mutations
in the TRPC6 gene that codes for a slit diaphragm–associated, cation-permeable ion …
in the TRPC6 gene that codes for a slit diaphragm–associated, cation-permeable ion …
A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression
MA Saleem, MJ O'Hare, J Reiser… - Journal of the …, 2002 - journals.lww.com
ABSTRACT. Recent molecular insights have established the podocyte as a key component
of the glomerular filtration barrier, and hence an important common pathway in proteinuric …
of the glomerular filtration barrier, and hence an important common pathway in proteinuric …
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A
…, JM Chang, HY Choi, KN Campbell, K Kim, J Reiser… - Nature medicine, 2008 - nature.com
The immunosuppressive action of the calcineurin inhibitor cyclosporine A (CsA) stems from
the inhibition of nuclear factor of activated T cells (NFAT) signaling in T cells. CsA is also …
the inhibition of nuclear factor of activated T cells (NFAT) signaling in T cells. CsA is also …
Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines
P Mundel, J Reiser, AZM Borja, H Pavenstädt… - Experimental cell …, 1997 - Elsevier
Mature podocytes are among the most complex differentiated cells and possess a highly
branched array of foot processes that are essential to glomerular filtration in the kidney. Such …
branched array of foot processes that are essential to glomerular filtration in the kidney. Such …
TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function
J Reiser, KR Polu, CC Möller, P Kenlan, MM Altintas… - Nature …, 2005 - nature.com
Progressive kidney failure is a genetically and clinically heterogeneous group of disorders.
Podocyte foot processes and the interposed glomerular slit diaphragm are essential …
Podocyte foot processes and the interposed glomerular slit diaphragm are essential …
Factors associated with death in critically ill patients with coronavirus disease 2019 in the US
…, EJ Schenck, J Radbel, J Reiser… - JAMA internal …, 2020 - jamanetwork.com
Importance The US is currently an epicenter of the coronavirus disease 2019 (COVID-19)
pandemic, yet few national data are available on patient characteristics, treatment, and …
pandemic, yet few national data are available on patient characteristics, treatment, and …
[HTML][HTML] Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin
K Schwarz, M Simons, J Reiser… - The Journal of …, 2001 - Am Soc Clin Investig
NPHS2 was recently identified as a gene whose mutations cause autosomal recessive
steroid-resistant nephrotic syndrome. Its product, podocin, is a new member of the stomatin family…
steroid-resistant nephrotic syndrome. Its product, podocin, is a new member of the stomatin family…
Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19
…, EJ Schenck, J Radbel, J Reiser… - JAMA internal …, 2021 - jamanetwork.com
Importance Therapies that improve survival in critically ill patients with coronavirus disease
2019 (COVID-19) are needed. Tocilizumab, a monoclonal antibody against the interleukin 6 …
2019 (COVID-19) are needed. Tocilizumab, a monoclonal antibody against the interleukin 6 …